FR2843304B1 - Extraits de sangsues pour stents - Google Patents

Extraits de sangsues pour stents

Info

Publication number
FR2843304B1
FR2843304B1 FR0210042A FR0210042A FR2843304B1 FR 2843304 B1 FR2843304 B1 FR 2843304B1 FR 0210042 A FR0210042 A FR 0210042A FR 0210042 A FR0210042 A FR 0210042A FR 2843304 B1 FR2843304 B1 FR 2843304B1
Authority
FR
France
Prior art keywords
stents
extracts
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0210042A
Other languages
English (en)
Other versions
FR2843304A1 (fr
Inventor
Jacques Latrille
Guennady I Nikonov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RICARIMPEX
Original Assignee
RICARIMPEX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RICARIMPEX filed Critical RICARIMPEX
Priority to FR0210042A priority Critical patent/FR2843304B1/fr
Priority to EP03756529A priority patent/EP1527169A2/fr
Priority to AU2003282192A priority patent/AU2003282192A1/en
Priority to JP2004526981A priority patent/JP2005534331A/ja
Priority to PCT/FR2003/002473 priority patent/WO2004015096A2/fr
Priority to US10/523,937 priority patent/US20060110425A1/en
Publication of FR2843304A1 publication Critical patent/FR2843304A1/fr
Application granted granted Critical
Publication of FR2843304B1 publication Critical patent/FR2843304B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/426—Immunomodulating agents, i.e. cytokines, interleukins, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/626—Liposomes, micelles, vesicles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
FR0210042A 2002-08-07 2002-08-07 Extraits de sangsues pour stents Expired - Fee Related FR2843304B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0210042A FR2843304B1 (fr) 2002-08-07 2002-08-07 Extraits de sangsues pour stents
EP03756529A EP1527169A2 (fr) 2002-08-07 2003-08-06 Extraits de sangsues pour stents
AU2003282192A AU2003282192A1 (en) 2002-08-07 2003-08-06 Leech extracts for stents
JP2004526981A JP2005534331A (ja) 2002-08-07 2003-08-06 ステント用のヒル抽出物
PCT/FR2003/002473 WO2004015096A2 (fr) 2002-08-07 2003-08-06 Extraits de sangsues pour stents
US10/523,937 US20060110425A1 (en) 2002-08-07 2003-08-06 Leech extracts for stents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0210042A FR2843304B1 (fr) 2002-08-07 2002-08-07 Extraits de sangsues pour stents

Publications (2)

Publication Number Publication Date
FR2843304A1 FR2843304A1 (fr) 2004-02-13
FR2843304B1 true FR2843304B1 (fr) 2005-12-16

Family

ID=30470988

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0210042A Expired - Fee Related FR2843304B1 (fr) 2002-08-07 2002-08-07 Extraits de sangsues pour stents

Country Status (6)

Country Link
US (1) US20060110425A1 (fr)
EP (1) EP1527169A2 (fr)
JP (1) JP2005534331A (fr)
AU (1) AU2003282192A1 (fr)
FR (1) FR2843304B1 (fr)
WO (1) WO2004015096A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2884829B1 (fr) * 2005-04-22 2008-01-11 Ricarimpex Procede d'obtention d'un extrait bacterien d'aeromonas hydrophila provenant de sangsues, et compositions pharmaceutiques les contenant
US8709473B1 (en) * 2009-01-28 2014-04-29 Abbott Cardiovascular Systems Inc. Method of targeting hydrophobic drugs to vascular lesions
CN105307634B (zh) * 2013-03-15 2020-03-10 沃纳奇尔科特有限责任公司 含有改性瓜尔胶的药物软明胶胶囊剂型
RU2560839C1 (ru) * 2014-03-20 2015-08-20 Общество с ограниченной ответственностью "Малое инновационное предприятие Центр экологических и оздоровительных технологий" Состав косметического средства геропротекторного действия

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243196B (it) * 1990-08-03 1994-05-24 Arval Spa Fogli di collagene nativo liofilizzato contenenti formulati cosmetici per il trattamento della couperose
RU2112528C1 (ru) * 1994-12-23 1998-06-10 Институт биоорганической химии им.М.М.Шемякина и Ю.А.Овчинникова РАН СПОСОБ ПОЛУЧЕНИЯ ФЕРМЕНТА ДЕСТАБИЛАЗЫ, ОБЛАДАЮЩЕГО ФИБРИНОЛИТИЧЕСКОЙ, ТРОМБОЛИТИЧЕСКОЙ, ЭНДО- И ЭКЗО- ε(γ GLY)-LYS-ИЗОПЕПТИДАЗНОЙ И АМИДОЛИТИЧЕСКОЙ АКТИВНОСТЬЮ
RU2129429C1 (ru) * 1995-09-05 1999-04-27 Московское акционерное общество "Биокон" Способ выделения комплекса дестабилаза - простагландин из медицинской пиявки
CA2268009A1 (fr) * 1996-10-15 1998-04-23 The Procter & Gamble Company Compositions detergentes comprenant une isopeptidase
WO2001047572A2 (fr) * 1999-12-29 2001-07-05 Advanced Cardiovascular Systems, Inc. Dispositif et constituant actif destines a inhiber la formation de thrombus-matrice cellulaire inflammatoire

Also Published As

Publication number Publication date
US20060110425A1 (en) 2006-05-25
FR2843304A1 (fr) 2004-02-13
WO2004015096A8 (fr) 2005-05-06
EP1527169A2 (fr) 2005-05-04
JP2005534331A (ja) 2005-11-17
WO2004015096A3 (fr) 2004-04-08
AU2003282192A1 (en) 2004-02-25
WO2004015096A2 (fr) 2004-02-19

Similar Documents

Publication Publication Date Title
DE60236093D1 (de) Entfernbarer stent
DE60312054D1 (de) Prothese
DE50112209D1 (de) Stent
DE60332187D1 (de) Endoluminale Prothese
DE60332977D1 (de) Endoprothese
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DE60320159D1 (de) Kniegelenkprothese
ATE407644T1 (de) Gelenkendoprothese
ITUD20030092A1 (it) Protesi per l'articolazione della spalla.
DK1658023T3 (da) Ankelledsendoprotese
DE60234439D1 (de) Stent zur ableitung von körperflüssigkeiten
DK1803718T3 (da) 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
FR2826256B1 (fr) Prothese pour epaule traumatique
DK1411926T3 (da) Integrininhibitorer til behandling af öjensygdomme
DE60216157D1 (de) Knieprothese
DE60230088D1 (de) Prothetisches Implantat
DE60232573D1 (de) Damenbinde
MA26341A1 (fr) Stents
FR2841960B1 (fr) Bague de traversee de cloison
BR0201121B1 (pt) absorvente higiênico
FR2843304B1 (fr) Extraits de sangsues pour stents
FR2843883B1 (fr) Extraits de sangsues pour psoriasis
FR2875127B1 (fr) Prothese de poignet
FR2833479B1 (fr) Prothese de genou
FR2844197B1 (fr) Solution pour application ungueale et peri-ungeale

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130430